BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4648589)

  • 1. Loss of protective activity of BALB-c spleen homogenate against cell-free transmission of HIPA-plasmacytoma by pretreatment with mineral oil of spleen-donor mice.
    Pedio G; Rüttner JR; Odermatt BF
    Pathol Microbiol (Basel); 1972; 38(5):375-8. PubMed ID: 4648589
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the oncogenesia of plasmacytoma (LPC-1). Transplantable neoplasm (HIPA) with plasma cell evolution, induced by spleen homogenate from a BALB-c mouse treated with mineral oil. 1. Biology and histology].
    Pedio G; Grieshaber E; Rüttner JR
    Pathol Microbiol (Basel); 1968; 31(5):278-86. PubMed ID: 5687787
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of HIPA plasmacytoma cell-free transmission by normal spleen of BALB-c, DBA-2 and C3H mice.
    Pedio G; Rüttner JR
    Int J Cancer; 1971 Nov; 8(3):497-502. PubMed ID: 5137311
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of lipopolysaccharide in the production of plasma cell tumors in mice given mineral oil injections.
    Platica M; Hollander VP
    Cancer Res; 1978 Mar; 38(3):703-5. PubMed ID: 626974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of mice against Corynebacterium pseudotuberculosis infection.
    Cameron CM; Minnaar JL
    Onderstepoort J Vet Res; 1969 Dec; 36(2):207-10. PubMed ID: 5407585
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental murine amyloidosis. Evaluation of induction methods and strain difference.
    Suzuki T; Ishikawa S; Motoyama T; Oboshi S
    Acta Pathol Jpn; 1980 Jul; 30(4):549-56. PubMed ID: 7415837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses and side effects of five different oil-based adjuvants in mice.
    Leenaars M; Koedam MA; Hendriksen CF; Claassen E
    Vet Immunol Immunopathol; 1998 Feb; 61(2-4):291-304. PubMed ID: 9613442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternatives to pristane priming for ascitic fluid and monoclonal antibody production.
    Gillette RW
    J Immunol Methods; 1987 May; 99(1):21-3. PubMed ID: 3571991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of parenteral administration of mineral oil adjuvant in parturient cattle on immunoglobulin secretion in colostrum and milk.
    De Cueninck BJ
    Am J Vet Res; 1981 Mar; 42(3):478-80. PubMed ID: 7271013
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of intraperitoneal administration of mineral oil in BALB-c mice: morphological patterns and blood changes].
    Invernizzi F; Galetti G; Fantini F; Mignone V
    Reumatismo; 1968; 20(2):136-9. PubMed ID: 5748162
    [No Abstract]   [Full Text] [Related]  

  • 11. On plasmocytoma--oncogenesis of mice. II. Differential ultracentrifugate which contains RNA virus-like particles from HIPA tumor inducing a plasmocytoid neoplasia in BALB-c mice.
    Pedio G; Grieshaber E; Rüttner JR
    Pathol Microbiol (Basel); 1968; 32(5):241-53. PubMed ID: 5742172
    [No Abstract]   [Full Text] [Related]  

  • 12. Production of polyclonal antibodies in ascitic fluid of mice: technique and applications.
    Overkamp D; Mohammed-Ali S; Cartledge C; Landon J
    J Immunoassay; 1988; 9(1):51-68. PubMed ID: 3283169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methodical modifications to optimize granulomatous lung changes in animal experiment (author's transl)].
    Eckert H; Lux M; Szymanska D
    Z Erkr Atmungsorgane; 1981 May; 157(2):230-2. PubMed ID: 7314698
    [No Abstract]   [Full Text] [Related]  

  • 14. An evaluation of distress following intraperitoneal immunization with Freund's adjuvant in mice.
    Toth LA; Dunlap AW; Olson GA; Hessler JR
    Lab Anim Sci; 1989 Mar; 39(2):122-6. PubMed ID: 2709800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental plasmacytomas in relation to human multiple myeloma.
    Azar HA
    Ann Clin Lab Sci; 1974; 4(3):157-63. PubMed ID: 4825619
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in resistance to tumor development in various strains of mice exposed to immunologic agents during the neonatal period].
    Volegov AI
    Biull Eksp Biol Med; 1981 Dec; 92(12):711-2. PubMed ID: 7326422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat monoclonal antibodies. VII. Enhancement of ascites production and yield of monoclonal antibodies in rats following pretreatment with pristane and Freund's adjuvant.
    Kints JP; Manouvriez P; Bazin H
    J Immunol Methods; 1989 May; 119(2):241-5. PubMed ID: 2723442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The allogeneic effect on tumor growth. II. Suppression of both ascitic and solid MOPC 315 plasmacytoma by the graft-vs-host reaction, with pathologic correlation.
    Osborne DP; Katz DH
    J Immunol; 1977 Apr; 118(4):1449-55. PubMed ID: 15035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody production by hybridoma growth in Freund's adjuvant primed mice.
    Mueller UW; Hawes CS; Jones WR
    J Immunol Methods; 1986 Mar; 87(2):193-6. PubMed ID: 3950429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic studies of macrophages. V. Effect of antigen and adjuvant stimulation.
    Gillette RW; Swanson MH
    J Reticuloendothel Soc; 1974 Jan; 15(1):31-40. PubMed ID: 4810599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.